⌘K
Loading ticker…
As of 2026-08-24, XBiotech Inc (XBIT) has a 3-month relative strength percentile of 38 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.9%, relative volume 1.06×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
XBIT is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 0.3% / -3.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
XBIT is held by 2 ETFs as of May 2026. Top owner: AVSC at 0.00% weight, $32K notional.
Held by 5 ETFs · $777K across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVSC | 0.00% | $32K | — |
| AVUVAvantis U.S. Small Cap Value ETF | 0.00% | $12K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XBIT Jan avg: 7.82% median: 9.88% win: 75% σ: 15.54% n: 4 2022-04-12 → 2026-07-31 | XBIT Feb avg: 1.35% median: -4.11% win: 50% σ: 25.41% n: 4 2022-04-12 → 2026-07-31 | XBIT Mar avg: 7.14% median: 3.33% win: 75% σ: 16.07% n: 4 2022-04-12 → 2026-07-31 | XBIT Apr avg: -2.48% median: -5.66% win: 20% σ: 7.42% n: 5 2022-04-12 → 2026-07-31 | XBIT May avg: 0.29% median: -5.84% win: 20% σ: 28.57% n: 5 2022-04-12 → 2026-07-31 | XBIT Jun avg: -2.18% median: 2.36% win: 60% σ: 16.93% n: 5 2022-04-12 → 2026-07-31 | XBIT Jul avg: 4.26% median: -3.04% win: 20% σ: 26.20% n: 5 2022-04-12 → 2026-07-31 | XBIT Aug avg: -8.19% median: -9.64% win: 25% σ: 14.29% n: 4 2022-04-12 → 2026-07-31 (current) | XBIT Sep avg: -5.26% median: -12.77% win: 25% σ: 17.61% n: 4 2022-04-12 → 2026-07-31 | XBIT Oct avg: -4.83% median: -4.56% win: 25% σ: 5.50% n: 4 2022-04-12 → 2026-07-31 | XBIT Nov avg: -3.12% median: -4.81% win: 25% σ: 5.59% n: 4 2022-04-12 → 2026-07-31 | XBIT Dec avg: -8.11% median: 3.66% win: 75% σ: 26.78% n: 4 2022-04-12 → 2026-07-31 |